Inhibition of the Interferon Response by West Nile Virus
西尼罗河病毒对干扰素反应的抑制
基本信息
- 批准号:7491029
- 负责人:
- 金额:$ 37.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-01 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntiviral AgentsAntiviral TherapyBindingBiochemicalBiochemical GeneticsBiological AssayCellsCessation of lifeComplexDevelopmentElderlyEncephalitisFamily memberFlaviviridaeFlavivirusGenesGeneticGoalsHepatitis BHepatitis C virusHumanImmune responseImmune systemInfectionInterferon ActivationInterferon-alphaInterferonsInvestigationJAK1 geneJanus kinaseKnowledgeNatureOutcomeParalysedPathogenesisPhosphorylationPlayProcessProtein Tyrosine KinaseProtein Tyrosine PhosphatasePurposeResearchRoleSignal Transduction PathwayStagingStructural ProteinSystemTYK2TestingVaccinationViralViral ProteinsVirusVirus DiseasesVirus ReplicationWest Nile virusWorkbasedesigngenetic analysismutantpathogenpreventprogramsreceptorresearch studyresponsestable cell linevirus host interaction
项目摘要
DESCRIPTION (provided by applicant): Our investigations of the innate immune response against West Nile virus (WNV), led to the discovery that WNV replication inhibits the signal transduction pathways used by interferons to induce cellular antiviral programs. The results indicated that one or more viral non-structural (NS) proteins inhibit the phosphorylation and activation of the Janus kinases JAK1 and Tyk2, which is required to establish an antiviral state in response to IFN. The purpose of the proposed research program is to investigate the mechanism responsible for this inhibition of the IFN response through three specific aims.
In the first aim, we will use a genetic approach to identify the viral protein(s) that are responsible for the observed inhibition of the IFNa response in WNV infected cells. Our goal is to identify replication competent WNV mutants that have lost the ability to inhibit the IFN response. With a biochemical approach described in the second aim, we will investigate the host-virus interactions that play a role in the inhibition of the IFN signal transduction pathway in WNV infected cells. Specifically, we will determine if viral proteins inhibit the IFN response directly through binding to the IFNa receptor complex or if they operate indirectly by activating a cellular antagonist, such as a protein tyrosine phosphatase or other known negative regulators of the IFN response. Experiments were designed to identify the cellular factors that provide targets for the viral antagonists. With the third aim, we will investigate how the relationship between the host innate immune response and viral components influences the outcome of WNV infections. With the help of a system permitting the conditional expression of IFN-induced genes, we will investigate how cellular antiviral mechanisms inhibit WNV replication and determine the nature of the cellular genes that constitute the innate antiviral program against WNV.
WNV has emerged as a pathogen of global significance that can cause paralysis, meningo-encephalitis, and death. Primary WNV infections cannot yet be prevented by vaccination and, so far, treatments to prevent the serious consequences of infections that affect particularly the elderly are not yet available. The studies proposed here will provide a better understanding of host-virus interactions that control WNV replication and pathogenesis. This new information can be used as the basis for the development of effective antiviral therapies.
描述(由申请人提供):我们对西尼罗病毒(WNV)先天免疫应答的研究,导致发现西尼罗病毒复制抑制干扰素用于诱导细胞抗病毒程序的信号转导途径。结果表明,一种或多种病毒非结构(NS)蛋白抑制Janus激酶JAK1和Tyk2的磷酸化和激活,而这是在IFN作用下建立抗病毒状态所必需的。拟议的研究计划的目的是通过三个具体目标来研究抑制IFN反应的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christoph Seeger其他文献
Christoph Seeger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christoph Seeger', 18)}}的其他基金
Designer Nucleases to Cure Chronic Hepatitis B
设计核酸酶可治愈慢性乙型肝炎
- 批准号:
8608995 - 财政年份:2013
- 资助金额:
$ 37.74万 - 项目类别:
Designer Nucleases to Cure Chronic Hepatitis B
设计核酸酶可治愈慢性乙型肝炎
- 批准号:
8424659 - 财政年份:2013
- 资助金额:
$ 37.74万 - 项目类别:
Mechanism of CCC DNA Synthesis in Hepatitis B Virus
乙型肝炎病毒CCC DNA合成机制
- 批准号:
8495929 - 财政年份:2012
- 资助金额:
$ 37.74万 - 项目类别:
Mechanism of CCC DNA Synthesis in Hepatitis B Virus
乙型肝炎病毒CCC DNA合成机制
- 批准号:
8355689 - 财政年份:2012
- 资助金额:
$ 37.74万 - 项目类别:
Inhibition of the Interferon Response by West Nile Virus
西尼罗河病毒对干扰素反应的抑制
- 批准号:
7676081 - 财政年份:2007
- 资助金额:
$ 37.74万 - 项目类别:
Inhibition of the Interferon Response by West Nile Virus
西尼罗河病毒对干扰素反应的抑制
- 批准号:
7919309 - 财政年份:2007
- 资助金额:
$ 37.74万 - 项目类别:
Inhibition of the Interferon Response by West Nile Virus
西尼罗河病毒对干扰素反应的抑制
- 批准号:
7322886 - 财政年份:2007
- 资助金额:
$ 37.74万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 37.74万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 37.74万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 37.74万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 37.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 37.74万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 37.74万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 37.74万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 37.74万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 37.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 37.74万 - 项目类别: